Status:

COMPLETED

Lung Ultrasound Score in Covid 19 Infectious Disease in Critical Care (LUS-COVID19)

Lead Sponsor:

Centre Hospitalier Universitaire de Nice

Conditions:

COVID

Eligibility:

All Genders

18-95 years

Brief Summary

It might be necessary with Sars-Cov2 pneumopathy patient to repeat thoracic images, the tomodensitometry ones in particular. This task is difficult and nearly impossible for several reasons: respirato...

Eligibility Criteria

Inclusion

  • Diagnosed Sars-Cov2 patient, with PCR method qualitative or quantitative as usual.
  • Intensive or critical care admission
  • ARDS with PaO2/FiO2 \<300 at the admission
  • Ventilatory support or oxygen-therapy

Exclusion

  • Age \< 18 years-old
  • Pregnancy
  • Patient with tutor- or curatorship or in prison

Key Trial Info

Start Date :

March 20 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 31 2022

Estimated Enrollment :

14 Patients enrolled

Trial Details

Trial ID

NCT04393402

Start Date

March 20 2020

End Date

December 31 2022

Last Update

April 10 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CHU de Nice

Nice, France, 06202